share_log

Mizuho Initiates Coverage On LifeMD With Neutral Rating, Announces Price Target of $7

Benzinga ·  06:08  · Ratings

Mizuho analyst Steven Valiquette initiates coverage on LifeMD (NASDAQ:LFMD) with a Neutral rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment